ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,452Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 252

$1.18M Total Retail Price of All Prescriptions

Rank: 9 out of 252

797 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 797 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 797 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 19,658 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
WARFARIN SODIUM 766 672 1 14
LEVOTHYROXINE SODIUM 765 665 2 1
SIMVASTATIN 734 582 3 2
FUROSEMIDE 723 616 4 7
OMEPRAZOLE 699 578 5 6
HYDROCODONE-ACETAMINOPHEN 660 380 S3 6 5
AMLODIPINE BESYLATE 593 547 7 4
LISINOPRIL 588 468 8 3
POTASSIUM CHLORIDE 536 492 9 8
METFORMIN HCL 482 368 10 9
GABAPENTIN 405 334 11 11
HYDROCHLOROTHIAZIDE 389 336 12 13
ZOLPIDEM TARTRATE 387 239 13 21
CITALOPRAM HBR 380 317 14 15
MELOXICAM 375 322 15 20
TRAMADOL HCL 362 273 16 17
NEXIUM 314 193 17 23
LOVASTATIN 306 245 18 39
FLUTICASONE PROPIONATE 298 222 19 36
METOPROLOL TARTRATE 278 254 20 10
ATORVASTATIN CALCIUM 238 197 21 16
TAMSULOSIN HCL 214 202 22 26
ATENOLOL 208 176 23 18
POLYETHYLENE GLYCOL 3350 207 186 24 67
CARVEDILOL 204 180 25 22
NAMENDA 201 201 26 41
AMLODIPINE BESYLATE-BENAZEPRIL 189 155 27 60
SERTRALINE HCL 184 150 28 27
EVISTA 181 180 29 91
LOSARTAN-HYDROCHLOROTHIAZIDE 172 140 30 49
LOSARTAN POTASSIUM 168 160 31 24
TRIAMTERENE-HCTZ 168 141 31 33
PRAVASTATIN SODIUM 166 133 33 12
MIRTAZAPINE 158 158 34 58
DONEPEZIL HCL 153 153 35 28
TIZANIDINE HCL 148 51 36 129
NOVOLOG 147 127 37 106
PAROXETINE HCL 145 123 38 75
FENOFIBRATE 144 94 39 64
TERAZOSIN HCL 143 119 40 94
ESCITALOPRAM OXALATE 143 85 40 56
CEPHALEXIN 136 124 42 121
CYCLOBENZAPRINE HCL 136 61 R 42 51
CYMBALTA 127 52 44 45
AZITHROMYCIN 125 97 45 37
ALENDRONATE SODIUM 125 125 45 32
AMITRIPTYLINE HCL 124 82 R 47 46
ROPINIROLE HCL 123 109 48 84
FAMOTIDINE 122 106 49 59
CLOPIDOGREL 122 109 49 29
PREDNISONE 114 101 51 42
DIOVAN 113 113 52 38
DIGOXIN 112 110 53 44
QUETIAPINE FUMARATE 106 104 54 77
LYRICA 106 86 54 66
LEVOFLOXACIN 102 75 56 79
METOCLOPRAMIDE HCL 100 66 57 110
DILTIAZEM 24HR CD 97 94 58 104
CELEBREX 95 81 59 101
ESTRADIOL 94 75 R 60 76
FLUOXETINE HCL 92 46 61 57
OXYBUTYNIN CHLORIDE ER 91 65 62 181
JANUVIA 91 76 62 88
VENLAFAXINE HCL ER 90 67 64 105
METHYLPREDNISOLONE 89 70 65 118
CLONIDINE HCL 89 77 65 35
CARISOPRODOL 88 21 R 67 70
BACLOFEN 88 52 67 158
PREMARIN 87 77 R 69 116
PROMETHAZINE HCL 87 24 R 69 85
TRAZODONE HCL 86 65 71 31
PLAVIX 84 80 72 43
DILTIAZEM ER 84 58 72 86
LISINOPRIL-HYDROCHLOROTHIAZIDE 84 71 72 25
METOPROLOL SUCCINATE 83 68 75 19
PROAIR HFA 78 59 76 54
ALLOPURINOL 77 69 77 30
BYSTOLIC 77 72 77 99
SULFAMETHOXAZOLE-TRIMETHOPRIM 76 64 79 87
ISOSORBIDE MONONITRATE ER 76 73 79 50
PANTOPRAZOLE SODIUM 74 74 81 62
DIVALPROEX SODIUM 74 50 81 113
SYNTHROID 73 73 83 47
NYSTATIN 73 67 83 171
SINGULAIR 72 47 85 100
NYSTOP 69 47 86 225
MECLIZINE HCL 69 62 86 136
FELODIPINE ER 67 67 88 161
HYDRALAZINE HCL 66 57 89 95
GLYBURIDE-METFORMIN HCL 66 42 R 89 82
TRIAMCINOLONE ACETONIDE 66 50 89 147
ALBUTEROL SULFATE 64 63 92 170
VENLAFAXINE HCL 64 52 92 160
OXYCODONE-ACETAMINOPHEN 63 54 S2 94 144
AMOX TR-POTASSIUM CLAVULANATE 63 50 94 132
ZALEPLON 63 48 94 326
DICYCLOMINE HCL 63 38 94 216
MEGACE ES 61 61 R 98 332
VENTOLIN HFA 61 36 98 102
BUSPIRONE HCL 60 56 100 119
RAMIPRIL 57 45 101 71
ZETIA 57 43 101 97
VERAPAMIL ER 57 43 101 83
CARBIDOPA-LEVODOPA 57 45 101 107
MORPHINE SULFATE ER 57 28 S2 101 127
BENAZEPRIL HCL 57 56 101 80
GLIPIZIDE ER 57 38 101 90
LEVEMIR 56 32 108 180
SUCRALFATE 55 43 109 125
KLOR-CON M20 55 53 109 69
FENTANYL 55 45 S2 109 126
GLIPIZIDE 54 41 112 52
CEFDINIR 54 38 112 211
LACTULOSE 54 54 112 157
NAPROXEN 53 30 115 96
ENALAPRIL MALEATE 53 53 115 72
OXYBUTYNIN CHLORIDE 52 42 117 123
PROPRANOLOL HCL 52 39 117 111
MONTELUKAST SODIUM 52 32 117 153
DIOVAN HCT 51 50 120 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.